Iranian Red Crescent Medical Journal

Published by: Kowsar

Platelet-Rich Plasma Accelerates Bone Differentiation in Human Adipose-Derived Mesenchymal Stromal Cells: An Experimental Study

Maryam Cheraghzadeh 1 , Hana Hanaee-Ahvaz 2 , Alireza Kheirollah 3 and Hamid Galehdari 1 , *
Authors Information
1 Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
2 Stem Cell Technology Research Center, Tehran, Iran
3 Department of Biochemistry, Medical School, Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Iranian Red Crescent Medical Journal: December 2018, 20 (12); e81828
  • Published Online: November 12, 2018
  • Article Type: Research Article
  • Received: July 7, 2018
  • Revised: October 14, 2018
  • Accepted: October 16, 2018
  • DOI: 10.5812/ircmj.81828

To Cite: Cheraghzadeh M, Hanaee-Ahvaz H, Kheirollah A, Galehdari H. Platelet-Rich Plasma Accelerates Bone Differentiation in Human Adipose-Derived Mesenchymal Stromal Cells: An Experimental Study, Iran Red Crescent Med J. 2018 ; 20(12):e81828. doi: 10.5812/ircmj.81828.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Garg P, Mazur MM, Buck AC, Wandtke ME, Liu J, Ebraheim NA. Prospective review of mesenchymal stem cells differentiation into osteoblasts. Orthop Surg. 2017;9(1):13-9. doi: 10.1111/os.12304. [PubMed: 28276640].
  • 2. Saeed H, Ahsan M, Saleem Z, Iqtedar M, Islam M, Danish Z, et al. Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update. J Biomed Sci. 2016;23:41. doi: 10.1186/s12929-016-0254-3. [PubMed: 27084089]. [PubMed Central: PMC4833928].
  • 3. Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 2011;7(2):269-91. doi: 10.1007/s12015-010-9193-7. [PubMed: 20853072].
  • 4. Rubio-Azpeitia E, Andia I. Partnership between platelet-rich plasma and mesenchymal stem cells: In vitro experience. Muscles Ligaments Tendons J. 2014;4(1):52-62. [PubMed: 24932448]. [PubMed Central: PMC4049651].
  • 5. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905. [PubMed: 16923606].
  • 6. Knight MN, Hankenson KD. Mesenchymal stem cells in bone regeneration. Adv Wound Care (New Rochelle). 2013;2(6):306-16. doi: 10.1089/wound.2012.0420. [PubMed: 24527352]. [PubMed Central: PMC3842877].
  • 7. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36(12):1392-404. doi: 10.1016/j.injury.2005.07.019. [PubMed: 16102764].
  • 8. Hakelien AM, Bryne JC, Harstad KG, Lorenz S, Paulsen J, Sun J, et al. The regulatory landscape of osteogenic differentiation. Stem Cells. 2014;32(10):2780-93. doi: 10.1002/stem.1759. [PubMed: 24898411].
  • 9. Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J Transl Med. 2016;14(1):143. doi: 10.1186/s12967-016-0893-x. [PubMed: 27197967]. [PubMed Central: PMC4873990].
  • 10. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 2012;8(4):212-27. doi: 10.1038/nrendo.2011.234. [PubMed: 22290358]. [PubMed Central: PMC3589914].
  • 11. Wang N, Zhou Z, Liao X, Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life. 2009;61(6):566-71. doi: 10.1002/iub.204. [PubMed: 19472179].
  • 12. Hu YB, Li CB, Song N, Zou Y, Chen SD, Ren RJ, et al. Diagnostic value of microRNA for Alzheimer's disease: A systematic review and meta-analysis. Front Aging Neurosci. 2016;8:13. doi: 10.3389/fnagi.2016.00013. [PubMed: 26903857]. [PubMed Central: PMC4746262].
  • 13. Giza DE, Vasilescu C, Calin GA. Key principles of miRNA involvement in human diseases. Discoveries (Craiova). 2014;2(4). e34. doi: 10.15190/d.2014.26. [PubMed: 26317116]. [PubMed Central: PMC4547364].
  • 14. Mao AS, Mooney DJ. Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci U S A. 2015;112(47):14452-9. doi: 10.1073/pnas.1508520112. [PubMed: 26598661]. [PubMed Central: PMC4664309].
  • 15. Fernandes G, Yang S. Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering. Bone Res. 2016;4:16036. doi: 10.1038/boneres.2016.36. [PubMed: 28018706]. [PubMed Central: PMC5153571].
  • 16. Schwartz-Arad D, Levin L, Aba M. [The use of platelet rich plasma (PRP) and platelet rich fibrin (PRP) extracts in dental implantology and oral surgery]. Refuat Hapeh Vehashinayim (1993). 2007;24(1):51-5. 84. Hebrew. [PubMed: 17615992].
  • 17. Yoshida K, Sumita Y, Marukawa E, Harashima M, Asahina I. Effect of platelet-rich plasma on bone engineering with an alloplastic substitute containing BMP2. Biomed Mater Eng. 2013;23(3):163-72. doi: 10.3233/BME-130741. [PubMed: 23629530].
  • 18. Rodriguez IA, Growney Kalaf EA, Bowlin GL, Sell SA. Platelet-rich plasma in bone regeneration: Engineering the delivery for improved clinical efficacy. BioMed Res Int. 2014;2014. doi: 10.1155/2014/392398'.
  • 19. Wei B, Huang C, Zhao M, Li P, Gao X, Kong J, et al. Effect of mesenchymal stem cells and platelet-rich plasma on the bone healing of ovariectomized rats. Stem Cells Int. 2016;2016:9458396. doi: 10.1155/2016/9458396. [PubMed: 27994625]. [PubMed Central: PMC5141561 publication of this paper].
  • 20. Xu FT, Li HM, Yin QS, Liang ZJ, Huang MH, Chi GY, et al. Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro. Am J Transl Res. 2015;7(2):257-70. [PubMed: 25901195]. [PubMed Central: PMC4399090].
  • 21. Mariner PD, Johannesen E, Anseth KS. Manipulation of miRNA activity accelerates osteogenic differentiation of hMSCs in engineered 3D scaffolds. J Tissue Eng Regen Med. 2012;6(4):314-24. doi: 10.1002/term.435. [PubMed: 21706778]. [PubMed Central: PMC3184319].
  • 22. Baglio SR, Devescovi V, Granchi D, Baldini N. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene. 2013;527(1):321-31. doi: 10.1016/j.gene.2013.06.021. [PubMed: 23827457].
  • 23. Pakfar A, Irani S, Hanaee-Ahvaz H. Expressions of pathologic markers in PRP based chondrogenic differentiation of human adipose derived stem cells. Tissue Cell. 2017;49(1):122-30. doi: 10.1016/j.tice.2016.11.001. [PubMed: 27887732].
  • 24. Tavakolinejad S, Khosravi M, Mashkani B, Ebrahimzadeh Bideskan A, Sanjar Mossavi N, Parizadeh MR, et al. The effect of human platelet-rich plasma on adipose-derived stem cell proliferation and osteogenic differentiation. Iran Biomed J. 2014;18(3):151-7. [PubMed: 24842141]. [PubMed Central: PMC4048479].
  • 25. Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7):1128-39. doi: 10.1038/cdd.2015.168. [PubMed: 26868907]. [PubMed Central: PMC4946886].
  • 26. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 2010;285(33):25221-31. doi: 10.1074/jbc.M110.116137. [PubMed: 20551325]. [PubMed Central: PMC2919085].
  • 27. Gu Y, Ma L, Song L, Li X, Chen D, Bai X. miR-155 inhibits mouse osteoblast differentiation by suppressing SMAD5 expression. Biomed Res Int. 2017;2017:1893520. doi: 10.1155/2017/1893520. [PubMed: 28473977]. [PubMed Central: PMC5394354].
  • 28. Li C, Zhang P, Gu J. miR-29a modulates tumor necrosis factor-alpha-induced osteogenic inhibition by targeting Wnt antagonists. Dev Growth Differ. 2015;57(3):264-73. doi: 10.1111/dgd.12207. [PubMed: 25846459].
  • 29. Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical Wnt signaling. J Cell Biochem. 2009;108(1):216-24. doi: 10.1002/jcb.22243. [PubMed: 19565563]. [PubMed Central: PMC2888144].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments